Abbott Labs sees tariffs costing ‘a few hundred million dollars’ this year
Abbott Lab’s stock bucks a broad market selloff, after quarterly profit extends a long streak of beats on the back of strong demand for diabetes products.
Abbott Lab’s stock bucks a broad market selloff, after quarterly profit extends a long streak of beats on the back of strong demand for diabetes products.
